Clinical Trials
6 trialsNCT07601399 2026-05-22
An EAP Treatment Protocol of Zipalertinib
Taiho Oncology, Inc.
Available
NCT07128199 2026-05-05
REZILIENT4
Taiho Oncology, Inc.
Phase 3 Active not recruiting
NCT05967689 2026-04-03
REZILIENT2
Taiho Oncology, Inc.
Phase 2 Recruiting
NCT05973773 2026-03-10
REZILIENT3
Taiho Oncology, Inc.
Phase 3 Active not recruiting
NCT07229339 2026-02-05
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT04036682 2025-03-13
REZILIENT1
Cullinan Therapeutics Inc.
Phase 1/2 Active not recruiting